Product Recall for Tracrium® 25mg/2.5mL Ampoules

HPS Pharmacies wish to give notice that Aspen, in consultation with the Therapeutic Goods Administration (TGA), has issued a product recall for Tracrium^® as follows:

Tracrium^® Ampoules  
Atracurium besilate 25mg/2.5mL
ARTG 11008

This product recall was initiated following reports of glass particles in a batch supplied in Switzerland. There have not been any product complaints reported in Australia.

The only batch affected by this notice is: XP1S4 (Expiry: December 2025)

There is no shortage associated with this recall and there is adequate supply of recently manufactured Tracrium^® available.

Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Aspen on 1300 659 646 or your pharmacist at HPS Pharmacies.

Download PDF